[Form 4] NuSkin Enterprises, Inc. Insider Trading Activity
Edwina D. Woodbury, a director of Nu Skin Enterprises, Inc. (NUS), reported an acquisition of Class A common stock on 09/10/2025. The filing shows shares were acquired at a price of $11.52 under the company’s Deferred Compensation Plan via dividend reinvestment. Following the transaction, Ms. Woodbury beneficially owns 42,969 shares. The Form 4 was signed by an attorney-in-fact on 09/11/2025. The filing lists the transaction as a direct ownership change and notes the dividend reinvestment as the reason for the share increase.
Edwina D. Woodbury, una direttrice di Nu Skin Enterprises, Inc. (NUS), ha comunicato un'acquisizione di azioni ordinarie di Classe A il 09/10/2025. La pratica mostra che le azioni sono state acquisite al prezzo di $11.52 nell'ambito del piano di compensi differiti della società tramite reinvestimento dei dividendi. A seguito della transazione, la signora Woodbury detiene in modo beneficiario 42,969 azioni. Il Modulo 4 è stato firmato da un procuratore in fatto il 09/11/2025. La pratica annota la transazione come cambio di proprietà diretta e segnala il reinvestimento dei dividendi come motivo dell'aumento delle azioni.
Edwina D. Woodbury, una directora de Nu Skin Enterprises, Inc. (NUS), informó la adquisición de acciones ordinarias de Clase A el 09/10/2025. El expediente muestra que las acciones se adquirieron a un precio de $11.52 bajo el Plan de Compensación Diferida de la empresa mediante reinversión de dividendos. Tras la transacción, la Sra. Woodbury posee beneficiosamente 42,969 acciones. El Formulario 4 fue firmado por un procurador el 11/09/2025. El expediente enumera la transacción como un cambio de propiedad directa y señala la reinversión de dividendos como la razón del incremento de acciones.
Edwina D. Woodbury, Nu Skin Enterprises, Inc.(NUS)의 이사였던 EDWINA D. Woodbury가 2025년 9월 10일 Class A 보통주를 취득했다고 보고했습니다. 공시에는 회사의 이연 보상 계획을 통해 배당 재투자를 통해 주식이 취득되었다고 나와 있습니다. 거래 후 Woodbury 여사는 유익하게 42,969주를 소유합니다. Form 4는 2025년 9월 11일에 법정대리인에 의해 서명되었습니다. 공시는 이 거래를 직접 소유권 변경으로 목록화하고 배당 재투자를 주식 증가의 원인으로 지적합니다.
Edwina D. Woodbury, une administratrice de Nu Skin Enterprises, Inc. (NUS), a signalé l'acquisition d'actions ordinaires de catégorie A le 10/09/2025. Le dossier indique que les actions ont été acquises à un prix de $11.52 dans le cadre du plan de rémunération différée de la société par réinvestissement des dividendes. Suite à la transaction, Mme Woodbury détient bénéficiairement 42,969 actions. Le Formulaire 4 a été signé par un mandataire le 11/09/2025. Le dossier répertorie la transaction comme un changement de propriété directe et note le réinvestissement des dividendes comme la raison de l'augmentation du nombre d'actions.
Edwina D. Woodbury, eine Direktorin von Nu Skin Enterprises, Inc. (NUS), meldete am 10.09.2025 den Erwerb von Stammaktien der Klasse A. Die Einreichung zeigt, dass die Aktien zu einem Preis von $11.52 im Rahmen des Unternehmensplans zur vermehrten Vergütung durch Dividendenwiederanlage erworben wurden. Nach der Transaktion besitzt Frau Woodbury beneficiell 42.969 Aktien. Das Formular 4 wurde am 11.09.2025 von einem Bevollmächtigten unterschrieben. Die Einreichung führt die Transaktion als direkte Eigentumsänderung auf und weist darauf hin, dass die Dividendenwiederanlage der Grund für den Anstieg der Aktien ist.
إدوينا دي. وودبري، مديرة في Nu Skin Enterprises, Inc. (NUS)، أبلغت عن اكتساب أسهم عادية من الفئة أ في 09/10/2025. تشير الوثيقة إلى أن الأسهم تم اكتسابها بسعر $11.52 بموجب خطة التعويض المؤجل للشركة عبر إعادة استثمار الأرباح. عقب الصفقة، تملك السيدة وودبري بشكل مفيد 42,969 سهماً. تم توقيع النموذج 4 من قبل وكيل قانوني في 11/09/2025. تقرر الوثيقة بأن الصفقة هي تغير في الملكية المباشرة وتذكر أن إعادة استثمار الأرباح هي سبب زيادة عدد الأسهم.
Edwina D. Woodbury，Nu Skin Enterprises, Inc.（NUS）的董事，报告在 09/10/2025 取得 A 类普通股。 该申报显示，公司通过股息再投资的方式，在其延期薪酬计划下以 $11.52 的价格获得了股份。交易完成后，伍德伯里女士实际拥有 42,969 股。Form 4 于 2025/09/11 由代理人签署。申报将该交易列为直接所有权变更，并指出股息再投资是股票增持的原因。
- Director increased direct ownership to 42,969 shares, which can indicate continued alignment with shareholder interests
- Acquisition made via company Deferred Compensation Plan, a routine, structured mechanism (dividend reinvestment)
- None.
Insights
TL;DR: Director acquired shares through dividend reinvestment, modestly increasing direct holdings to 42,969 shares.
The Form 4 documents a routine, non-discretionary acquisition under Nu Skin's Deferred Compensation Plan. The transaction is coded as an acquisition at $11.52 per share and is recorded as direct beneficial ownership. This type of filing generally reflects an administrative increase in holdings rather than an active market purchase by the insider. The filing contains no indications of option exercise, derivative activity, or disposition of shares.
TL;DR: Governance-wise this is a standard dividend reinvestment disclosure by a director with no adverse governance signals.
The explanation states the shares were acquired via dividend reinvestment under the Deferred Compensation Plan, which is a common mechanism that aligns long-term compensation with share ownership. The filing is complete for the reported event and signed by an attorney-in-fact. There are no disclosures of related-party transactions or departures from standard Section 16 reporting practices.
Edwina D. Woodbury, una direttrice di Nu Skin Enterprises, Inc. (NUS), ha comunicato un'acquisizione di azioni ordinarie di Classe A il 09/10/2025. La pratica mostra che le azioni sono state acquisite al prezzo di $11.52 nell'ambito del piano di compensi differiti della società tramite reinvestimento dei dividendi. A seguito della transazione, la signora Woodbury detiene in modo beneficiario 42,969 azioni. Il Modulo 4 è stato firmato da un procuratore in fatto il 09/11/2025. La pratica annota la transazione come cambio di proprietà diretta e segnala il reinvestimento dei dividendi come motivo dell'aumento delle azioni.
Edwina D. Woodbury, una directora de Nu Skin Enterprises, Inc. (NUS), informó la adquisición de acciones ordinarias de Clase A el 09/10/2025. El expediente muestra que las acciones se adquirieron a un precio de $11.52 bajo el Plan de Compensación Diferida de la empresa mediante reinversión de dividendos. Tras la transacción, la Sra. Woodbury posee beneficiosamente 42,969 acciones. El Formulario 4 fue firmado por un procurador el 11/09/2025. El expediente enumera la transacción como un cambio de propiedad directa y señala la reinversión de dividendos como la razón del incremento de acciones.
Edwina D. Woodbury, Nu Skin Enterprises, Inc.(NUS)의 이사였던 EDWINA D. Woodbury가 2025년 9월 10일 Class A 보통주를 취득했다고 보고했습니다. 공시에는 회사의 이연 보상 계획을 통해 배당 재투자를 통해 주식이 취득되었다고 나와 있습니다. 거래 후 Woodbury 여사는 유익하게 42,969주를 소유합니다. Form 4는 2025년 9월 11일에 법정대리인에 의해 서명되었습니다. 공시는 이 거래를 직접 소유권 변경으로 목록화하고 배당 재투자를 주식 증가의 원인으로 지적합니다.
Edwina D. Woodbury, une administratrice de Nu Skin Enterprises, Inc. (NUS), a signalé l'acquisition d'actions ordinaires de catégorie A le 10/09/2025. Le dossier indique que les actions ont été acquises à un prix de $11.52 dans le cadre du plan de rémunération différée de la société par réinvestissement des dividendes. Suite à la transaction, Mme Woodbury détient bénéficiairement 42,969 actions. Le Formulaire 4 a été signé par un mandataire le 11/09/2025. Le dossier répertorie la transaction comme un changement de propriété directe et note le réinvestissement des dividendes comme la raison de l'augmentation du nombre d'actions.
Edwina D. Woodbury, eine Direktorin von Nu Skin Enterprises, Inc. (NUS), meldete am 10.09.2025 den Erwerb von Stammaktien der Klasse A. Die Einreichung zeigt, dass die Aktien zu einem Preis von $11.52 im Rahmen des Unternehmensplans zur vermehrten Vergütung durch Dividendenwiederanlage erworben wurden. Nach der Transaktion besitzt Frau Woodbury beneficiell 42.969 Aktien. Das Formular 4 wurde am 11.09.2025 von einem Bevollmächtigten unterschrieben. Die Einreichung führt die Transaktion als direkte Eigentumsänderung auf und weist darauf hin, dass die Dividendenwiederanlage der Grund für den Anstieg der Aktien ist.
FAQ
What transaction did Edwina D. Woodbury report on Form 4 for NUS?
How many Nu Skin (NUS) shares does the filing show Edwina Woodbury owns after the transaction?
What price per share is reported for the transaction?
Was the transaction direct or indirect ownership?
Why were the shares acquired according to the filing?
